Increased expression of CD38 (marker for activated stellate cell) and TLR1 (receptor for peptidoglycan and lipoprotein) in NAFLD rats was also consistent with a successful NAFLD model. Here, TLR1 is linked to metabolic dysfunction-associated steatotic liver disease.